Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 3 of 15

→ Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad)
Slide 3
Back to 2
Continue to 4
 
Back to 2
Continue to 4
 

United Therapeutics (NASDAQ:UTHR)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$308.78 (17.7% Upside)

About United Therapeutics

United Therapeutics logoUnited Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/3/2024The Goldman Sachs GroupBoost Price TargetNeutral ➝ Neutral$218.00 ➝ $240.00
5/2/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$375.00 ➝ $400.00
5/2/2024HC WainwrightReiterated RatingBuy ➝ Buy$300.00
3/7/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$309.00 ➝ $325.00
2/22/2024WedbushReiterated RatingOutperform ➝ Outperform$308.00
2/22/2024HC WainwrightReiterated RatingBuy ➝ Buy$300.00
2/12/2024The Goldman Sachs GroupUpgradeSell ➝ Neutral$213.00 ➝ $215.00
2/5/2024Leerink PartnrsReiterated RatingOutperform
2/5/2024SVB LeerinkInitiated CoverageOutperform$330.00
12/8/2023Wells Fargo & CompanyInitiated CoverageOverweight$309.00
Slide 3
Back to 2
Continue to 4
 

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

More From MarketBeat
Investors Alert: The Next Big Thing in Weight Loss
from Behind the Markets
The Top-Rated Dividend Stocks for 2023
from MarketBeat
Elon to Transform U.S. Economy?
from Porter & Company
20 Stocks Wall Street Analysts Love the Most
from MarketBeat
Automatic Income (from home)
from Awesomely, LLC
10 Best Penny Stocks to Buy Now
from MarketBeat